glutathione epigenetic drug resistance deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies Epigenetic modifications in cancer drug
Epigenetic modifications in cancer drug resistance: molecular mechanisms and therapeutic interventions Molecular Biomedicine Springer Nature Link Targeting epigenetic regulators as a promising avenue to overcome cancer therapy resistance Signal Transduction and Targeted Therapy Targeting epigenetic regulators to overcome drug resistance in cancers Signal Transduction and Targeted Therapy Glutathione S transferase Theta 2 causes drug resistance by inhibiting arsenic trioxide induced ferroptosis in pancreatic ductal adenocarcinoma ScienceDirect Drug Resistance in Cancer: An Overview
Pay in 4 interest-free payments of $5.71 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 4 - Aug 9




